Clinical Trial

A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)

Name: A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) — clinical trial record (NCT07717840)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ARIES

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This Phase I/II study is to characterize the safety and immunogenicity of 2 dose levels of AZD6489, an investigational RSV recombinant prefusion F protein VLP vaccine.

Trial Details

NCT Number	NCT07717840
Lead Sponsor	AstraZeneca
Conditions	RSV Respiratory Syncytial Virus
Enrollment	160 participants
Start Date	2026-07-08
Primary Completion	2026-10-15 (estimated)
Study Completion	2027-09-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-21